Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D P Miller

Showing results (91-100 of 94) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 94 results.
Circulation|July 1, 1997
First chronic platelet glycoprotein IIb/IIIa integrin blockade. A randomized, placebo-controlled pilot study of xemilofiban in unstable angina with percutaneous coronary interventionsC Simpfendorfer, K Kottke-Marchant, M Lowrie, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 9, 2000
Vaccine-induced antibodies inhibit CETP activity in vivo and reduce aortic lesions in a rabbit model of atherosclerosisC W Rittershaus, D P Miller, L J Thomas, et al.
Journal of the American Dental Association (1939)|January 25, 2002
An economic evaluation of a chlorhexidine chip for treating chronic periodontitis: the CHIP (chlorhexidine in periodontitis) studyC J Henke, K F Villa, M E Aichelmann-Reidy, et al.
The Journal of Biological Chemistry|April 10, 1999
Recombinant glycoproteins that inhibit complement activation and also bind the selectin adhesion moleculesC W Rittershaus, L J Thomas, D P Miller, et al.
Pageof 10

Showing results (91-100 of 94) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 94 results.
Circulation|July 1, 1997
First chronic platelet glycoprotein IIb/IIIa integrin blockade. A randomized, placebo-controlled pilot study of xemilofiban in unstable angina with percutaneous coronary interventionsC Simpfendorfer, K Kottke-Marchant, M Lowrie, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 9, 2000
Vaccine-induced antibodies inhibit CETP activity in vivo and reduce aortic lesions in a rabbit model of atherosclerosisC W Rittershaus, D P Miller, L J Thomas, et al.
Journal of the American Dental Association (1939)|January 25, 2002
An economic evaluation of a chlorhexidine chip for treating chronic periodontitis: the CHIP (chlorhexidine in periodontitis) studyC J Henke, K F Villa, M E Aichelmann-Reidy, et al.
The Journal of Biological Chemistry|April 10, 1999
Recombinant glycoproteins that inhibit complement activation and also bind the selectin adhesion moleculesC W Rittershaus, L J Thomas, D P Miller, et al.
Pageof 10